To Develop Contract Manufacturing
Amendments proposed to be introduced to the Federal Law on Drug Circulation have been presented for public discussion.
These changes will assist in marketing authorization of drugs with the same international nonproprietary name, but under different trademarks, manufactured at the same site. It will help develop the market of contract manufacture of drugs in the Russian Federation and give Russian manufacturers an opportunity to manufacture drugs of other manufacturers apart from own products.
It should be noted that the draft of law fully complies with provisions of the Agreement on Eurasia Economic Union of May 29, 2014 and provisions of other international agreements signed by the Russian Federation.
The discussion of the document will continue till January 26, 2017.